Dr. Felipe Jose Zinkewich, MD

Dr. Zinkewich practices at Loma Linda University Medical Center in Loma Linda, California, part of Seventh-day Adventist Church.

Dr. Zinkewich's NPI, 1568026789, was assigned on April 23, 2019. Dr. Zinkewich graduated from Jacobs School of Medicine and Biomedical Sciences in 2019. Dr. Zinkewich holds California license A176942.

Dr. Zinkewich's primary practice is Loma Linda University Medical Center, at 11234 Anderson St, Loma Linda, CA 92354 in San Bernardino County. The practice phone is (909) 558-4000.

Dr. Zinkewich's primary practice is Loma Linda University Medical Center in Loma Linda, California, part of Seventh-day Adventist Church. The medical group on file is Loma Linda University Faculty Medical Group (LLUFMG).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zinkewich practices. Vendor and product names are available with a free account.

Emergency medicine is Dr. Zinkewich's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Zinkewich is board certified in emergency medicine by the American Board of Emergency Medicine. Dr. Zinkewich is licensed in California.

CMS data shows 396 Medicare services from Dr. Zinkewich across 6 procedure codes in 2024, for 310 Medicare patients. Medicare paid $34,921 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 310 Medicare patients who saw Dr. Zinkewich in 2024. The largest group is 65 to 74, with 120 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 55% are also on Medicaid. Their average risk score is 2.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zinkewich's median patient age at 53, with 58% women.

In 2024, Dr. Zinkewich wrote 226 Medicare Part D claims for 154 patients. 91% of them were for generic drugs. CMS names the drug for 82 of them, across 5 drugs with 11 or more claims each, at $561 in total drug cost. In 2023, CMS named 114 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Zinkewich for performance year 2024, reported as part of a group. Dr. Zinkewich accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Zinkewich in 2022. Dr. Zinkewich's most frequent co-authors are Deena Ibrahim Bengiamin, MD, Ricardo Chujutalli, MD and Matthew Dalley.

Dr. Zinkewich graduated from Jacobs School of Medicine and Biomedical Sciences in 2019.

Dr. Zinkewich is in network with 8 carriers, including United Healthcare, Aspirus Health Plan and Blue Cross and Blue Shield of Kansas City. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.